Publication of evaluation reports in Europe and Australia makes information on medicines simply available.
Today in a joint article published by Drug Discovery, the European Medicines Agency (EMA) and the Therapeutic Goods Administration (TGA) in Australia depict their constructive experiences with the publication of evaluation reports for medicines – known as European public assessment reports (EPARs) in Europe and Australian Public Assessment Reports (AusPARs) in Australia.
According to the authors, growing web traffic depicts the regulators’ success in assisting access to medicines’ information and the validations for medicines’ approval.
By focusing on authenticate, evidence-based, and up-to-date information, EPARs and AusPARs throw in to the propagation of consistent facts on medicines and how they are appraised and guarantee transparency. The reports build on close and reliable interface with a wide range of stakeholders in order to reflect the perceptions of different audiences.
Scientific development and stakeholders’ desire for greater information need a permanent development in the communication of information on medicines. Both regulators widely collect feedback on the value of the published information to evaluate continuously how to best communicate high-quality information on medicines to users and researchers.
Dated: 05/08/2016